Why is Boston Bio falling/rising?

As of 15-Oct, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.63, which reflects a decrease of 0.4 or 4.98%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 9.7% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, down by 42.38% compared to the 5-day average, suggesting a reduction in investor participation. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, Boston Bio's performance over the past week shows a substantial decline of 15.88%, while the benchmark Sensex has increased by 1.02%. This stark contrast highlights the stock's underperformance relative to the market. Over the past month, Boston Bio has also decreased by 5.22%, while the Sensex has gained 1.00%. The ongoing decline in stock price, coupled with the lack of positive momentum and reduced trading activity, indicates that investor sentiment is currently negative, contributing to the stock's downward trajectory.